Literature DB >> 23602371

EGFR cooperates with glucose transporter SGLT1 to enable chromatin remodeling in response to ionizing radiation.

Klaus Dittmann1, Claus Mayer, H Peter Rodemann, Stephan M Huber.   

Abstract

BACKGROUND AND
PURPOSE: EGFR and the sodium-dependent glucose transporter, SGLT1, are found in complex after radiation treatment. The aim of this study was to elucidate the role of EGFR in glucose uptake and chromatin remodeling.
MATERIAL AND METHODS: Glucose accumulation was quantified with help of (3)H-glucose. Involvement of SGLT was detected by a specific inhibitor. Role of EGFR was proved by EGFR overexpression and siRNA driven knockdown. Functional endpoints were intracellular ATP levels, protein expression, residual DNA-damage and colony formation.
RESULTS: EGFR/SGLT1 interactions in response to ionizing radiation were associated with increased glucose uptake. Nevertheless, tumor cells exhibit ATP depletion following irradiation. Recovery from radiation-induced ATP crisis was EGFR/SGLT-dependent and associated with increased cell survival and improved DNA-repair. The blockage of either EGFR or SGLT inhibited ATP level recovery and histone H3 modifications crucial for both chromatin remodeling and DNA repair in response to irradiation. Inhibition of the acetyltransferase TIP60, which is essential for histone H3-K9 acetylation and ATM activation, prevented energy crisis and chromatin remodeling.
CONCLUSIONS: Radiation-associated interactions between SGLT1 and EGFR resulted in increased glucose uptake, which counteracts the ATP crisis in tumor cells due to chromatin remodeling. The blockage of recovery from ATP crisis led to radio-sensitization in tumor cells.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23602371     DOI: 10.1016/j.radonc.2013.03.016

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  14 in total

Review 1.  K+ channel signaling in irradiated tumor cells.

Authors:  Benjamin Stegen; Lukas Klumpp; Milan Misovic; Lena Edalat; Marita Eckert; Dominik Klumpp; Peter Ruth; Stephan M Huber
Journal:  Eur Biophys J       Date:  2016-05-10       Impact factor: 1.733

Review 2.  EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy.

Authors:  Cristina Zahonero; Pilar Sánchez-Gómez
Journal:  Cell Mol Life Sci       Date:  2014-03-27       Impact factor: 9.261

Review 3.  Opportunities and challenges of radiotherapy for treating cancer.

Authors:  Dörthe Schaue; William H McBride
Journal:  Nat Rev Clin Oncol       Date:  2015-06-30       Impact factor: 66.675

Review 4.  Ion Transport and Radioresistance.

Authors:  Bastian Roth; Stephan M Huber
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

5.  Transcriptional co-factor Transducin beta-like (TBL) 1 acts as a checkpoint in pancreatic cancer malignancy.

Authors:  Christian Stoy; Aishwarya Sundaram; Marcos Rios Garcia; Xiaoyue Wang; Oksana Seibert; Annika Zota; Susann Wendler; David Männle; Ulf Hinz; Carsten Sticht; Maria Muciek; Norbert Gretz; Adam J Rose; Vera Greiner; Thomas G Hofmann; Andrea Bauer; Jörg Hoheisel; Mauricio Berriel Diaz; Matthias M Gaida; Jens Werner; Tobias Schafmeier; Oliver Strobel; Stephan Herzig
Journal:  EMBO Mol Med       Date:  2015-08       Impact factor: 12.137

6.  Effects of Aptamer to U87-EGFRvIII Cells on the Proliferation, Radiosensitivity, and Radiotherapy of Glioblastoma Cells.

Authors:  Xingmei Zhang; Li Peng; Zhiman Liang; Zhewen Kou; Yue Chen; Guangwei Shi; Xiaowen Li; Yanling Liang; Fang Wang; Yusheng Shi
Journal:  Mol Ther Nucleic Acids       Date:  2018-01-08       Impact factor: 8.886

Review 7.  Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio.

Authors:  Marike W van Gisbergen; Emma Zwilling; Ludwig J Dubois
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244

8.  UCP-3 uncoupling protein confers hypoxia resistance to renal epithelial cells and is upregulated in renal cell carcinoma.

Authors:  Norbert Braun; Dominik Klumpp; Jörg Hennenlotter; Jens Bedke; Christophe Duranton; Martin Bleif; Stephan M Huber
Journal:  Sci Rep       Date:  2015-08-25       Impact factor: 4.379

9.  Ionizing radiation, ion transports, and radioresistance of cancer cells.

Authors:  Stephan M Huber; Lena Butz; Benjamin Stegen; Dominik Klumpp; Norbert Braun; Peter Ruth; Franziska Eckert
Journal:  Front Physiol       Date:  2013-08-14       Impact factor: 4.566

10.  Targeting TRPM2 Channels Impairs Radiation-Induced Cell Cycle Arrest and Fosters Cell Death of T Cell Leukemia Cells in a Bcl-2-Dependent Manner.

Authors:  Dominik Klumpp; Milan Misovic; Kalina Szteyn; Ekaterina Shumilina; Justine Rudner; Stephan M Huber
Journal:  Oxid Med Cell Longev       Date:  2015-12-29       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.